We are live on ! Find out more
CAPTRUST Financial Advisors

CAPTRUST Financial Advisors Portfolio holdings

AUM $65.5B
1-Year Est. Return 24.25%
This Fund
S&P 500
This Quarter Est. Return
+14.23%
1 Year Est. Return
+24.25%
3 Year Est. Return
+72.65%
5 Year Est. Return
+85.27%
10 Year Est. Return
+285.21%
AUM
$65.5B
AUM Growth
+$8.17B
Cap. Flow
+$2.07B
Cap. Flow %
3.16%
Top 10 Hldgs %
26.79%
Holding
3,427
New
411
Increased
1,662
Reduced
1,039
Closed
153

Sector Composition

Rank Sector Weight
1 Miscellaneous 51.01%
2 Technology 16.85%
3 Financials 7.2%
4 Industrials 4.88%
5 Healthcare 4.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EOD
3101
Allspring Global Dividend Opportunity Fund
EOD
$288M
$65.3K ﹤0.01%
10,000
ENVX icon
3102
Enovix
ENVX
$761M
$65K ﹤0.01%
+10,704
New +$71K
QSI icon
3103
Quantum-Si Incorporated
QSI
$166M
$64.7K ﹤0.01%
73,128
+4,092
+6% +$3.9K
AQST icon
3104
Aquestive Therapeutics
AQST
$654M
$64.7K ﹤0.01%
15,545
-455
-3% -$1.92K
AMC icon
3105
AMC Entertainment Holdings
AMC
$2.29B
$64.3K ﹤0.01%
33,850
+16,092
+91% +$27.7K
NAUT icon
3106
Nautilus Biotechnolgy
NAUT
$118M
$63.6K ﹤0.01%
34,000
-3
-0% -$8
SVRA icon
3107
Savara
SVRA
$1.14B
$63.6K ﹤0.01%
+10,319
New +$55.4K
ORBS
3108
Eightco Holdings
ORBS
$442M
$63.5K ﹤0.01%
91,347
+49,522
+118% +$44.6K
VTEX icon
3109
VTEX
VTEX
$585M
$62.1K ﹤0.01%
15,525
+938
+6% +$3.58K
QTRX icon
3110
Quanterix
QTRX
$129M
$61.8K ﹤0.01%
+14,301
New +$46.4K
AKBA icon
3111
Akebia Therapeutics
AKBA
$285M
$61.6K ﹤0.01%
+54,006
New +$64.3K
JELD icon
3112
JELD-WEN Holding
JELD
$190M
$61.3K ﹤0.01%
+40,891
New +$63K
ACCO icon
3113
Acco Brands
ACCO
$401M
$61.3K ﹤0.01%
14,724
+416
+3% +$1.53K
INV
3114
Innventure Inc
INV
$93.1M
$60.3K ﹤0.01%
+11,884
New +$69.9K
RCAX
3115
Defiance Daily Target 2x Long RCAT ETF
RCAX
$8.17M
$60.1K ﹤0.01%
+10,000
New +$91.7K
EXFY icon
3116
Expensify
EXFY
$216M
$60K ﹤0.01%
+33,529
New +$37.6K
DCH
3117
Dauch Corp
DCH
$1.66B
$59.8K ﹤0.01%
11,028
-436
-4% -$2.65K
MMT
3118
Aberdeen Multi-Market Income Fund
MMT
$243M
$59.2K ﹤0.01%
13,460
-5,796
-30% -$26.2K
BMBL icon
3119
Bumble
BMBL
$384M
$58.8K ﹤0.01%
18,371
-24,433
-57% -$83.6K
CTKB icon
3120
Cytek Biosciences
CTKB
$601M
$57.9K ﹤0.01%
13,068
-3,366
-20% -$14.4K
AAPL icon
3121
CALL
Apple
AAPL
$4.61T
$57.9K ﹤0.01%
+200
New +$57.2K
EGHT icon
3122
8x8 Inc
EGHT
$266M
$55.2K ﹤0.01%
32,293
-8,225
-20% -$16.6K
SANA icon
3123
Sana Biotechnology
SANA
$1.03B
$54.8K ﹤0.01%
15,713
-130
-0.8% -$419
LPRO
3124
DELISTED
Open Lending Corp
LPRO
$54.8K ﹤0.01%
17,626
-306
-2% -$625
PM icon
3125
PUT
Philip Morris
PM
$288B
$54.3K ﹤0.01%
300

Similar funds

CAPTRUST Financial Advisors's Q2 2026 Portfolio in Review

As of Q2 2026, CAPTRUST Financial Advisors held 3,427 positions worth $65.5B, up 14% from $57.3B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

CAPTRUST Financial Advisors deployed $2.07B of net new capital in Q2 2026, opening 411 new positions and adding to 1,662 existing holdings. Its largest new stake was Honeywell Aerospace: 167,752 shares worth $37.1M.

By sector, the portfolio is most concentrated in Miscellaneous at 51% of assets, down from 52% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Vanguard FTSE Developed Markets ETF, an estimated $121M trimmed.

  • CAPTRUST Financial Advisors's largest Q2 2026 buy was Honeywell Aerospace: 167,752 shares worth $37.1M.
  • CAPTRUST Financial Advisors added most to iShares Core S&P 500 ETF in Q2 2026, an estimated $256M increase.
  • CAPTRUST Financial Advisors's biggest Q2 2026 reduction was Vanguard FTSE Developed Markets ETF, cutting an estimated $121M.
  • CAPTRUST Financial Advisors fully exited ExxonMobil in Q2 2026, selling an estimated $242M.
  • CAPTRUST Financial Advisors's ten largest holdings make up 27% of its $65.5B portfolio in Q2 2026.
  • CAPTRUST Financial Advisors opened 411 new positions and closed 153 in Q2 2026.
  • CAPTRUST Financial Advisors's portfolio value rose 14% quarter-over-quarter to $65.5B.

Based on CAPTRUST Financial Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.